<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02066077</url>
  </required_header>
  <id_info>
    <org_study_id>SHDC12012109</org_study_id>
    <nct_id>NCT02066077</nct_id>
  </id_info>
  <brief_title>The Efficacy And Cognitive Impairment Of Modified Electroconvulsive Therapy</brief_title>
  <official_title>The Efficacy And Cognitive Impairment Of Modified Electroconvulsive Therapy: A Randomized Clinical Trial And Its Standard Technology Promotion Research</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Mental Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tongji Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Huashan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai Mental Health Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. To determine the influencing factors of modified electroconvulsive therapy (MECT);

        2. To determine the influencing factors and reversibility of the cognitive impairment
           caused by MECT;

        3. To determine the duration of efficacy of MECT and its affecting factors.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 1, 2013</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Hamilton Depression Scale(HAMD) Scores</measure>
    <time_frame>Change from Baseline in Hamilton Depression Scale scores at 7d, 14d, 21d, 28d, 35d, 42d and 180d after the last MECT session</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Wechsler Memory Scale (WMS) Scores as a Measure of Safety</measure>
    <time_frame>Change from Baseline in Wechsler Memory Scale (WMS) Scores at 42d and 180d after the last MECT session</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Young Manic Rating Scale(MMSE) as a Measure for Evaluation of Mania State</measure>
    <time_frame>42d and 180d after the last MECT session</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resting-state/Task-state functional magnetic resonance imaging (fMRI)</measure>
    <time_frame>Change form Baseline in Resting-state/Task-state fMRI Imging Results at 42d and 180d after the last MECT session</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Hamilton Anxiety Scale(HAMA) Scores</measure>
    <time_frame>Change from Baseline in Hamilton Anxiety Scale Scores at 7d, 14d, 21d, 28d, 35d, 42d and 180d after the last MECT session</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Clinical Global Impression-severity of illness(CGI-SI) Scores as a Measure of Efficacy</measure>
    <time_frame>Change from Baseline in CGI-SI Scores at 7d, 14d, 21d, 28d, 35d, 42d and 180d after the last MECT session</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Wisconsin Card Sorting Test(WCST) Scores as a Measure of Safety</measure>
    <time_frame>Change from Baseline in Wisconsin Card Sorting Test(WCST) Scores at 42d and 180d after the last MECT session</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in P300/P50 Event-Related Potentials(ERP)</measure>
    <time_frame>Change from Baseline in P300/P50 Event-Related Potentials(ERP) at 42d and 180d after after the last MECT session</time_frame>
  </secondary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Actual">280</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>Bilateral temporal and propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>During the MECT treatment, electrodes are placed at bilateral temporal, with propofol 2mg/kg to Induce anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bilateral temporal and etomidate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>During the MECT treatment, electrodes are placed at bilateral temporal, with etomidate 0.3mg/kg to Induce anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>The right temporal and propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>During the MECT treatment, electrodes are placed at the right temporal, with propofol 2mg/kg to Induce anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>The right temporal and etomidate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>During the MECT treatment, electrodes are placed at the right temporal, with etomidate 0.3mg/kg to Induce anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bilateral frontal and propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>During the MECT treatment, electrodes are placed at bilateral frontal, with propofol 2mg/kg to Induce anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bilateral frontal and etomidate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>During the MECT treatment, electrodes are placed at bilateral frontal, with etomidate 0.3mg/kg to Induce anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard-therapy Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>During the MECT treatment, electrodes are placed at bilateral temporal, with etomidate 0.3mg/kg to Induce anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Etomidate</intervention_name>
    <arm_group_label>Bilateral temporal and etomidate</arm_group_label>
    <arm_group_label>The right temporal and etomidate</arm_group_label>
    <arm_group_label>Bilateral frontal and etomidate</arm_group_label>
    <arm_group_label>Standard-therapy Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <arm_group_label>Bilateral temporal and propofol</arm_group_label>
    <arm_group_label>The right temporal and propofol</arm_group_label>
    <arm_group_label>Bilateral frontal and propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bilateral temporal MECT</intervention_name>
    <arm_group_label>Bilateral temporal and propofol</arm_group_label>
    <arm_group_label>Bilateral temporal and etomidate</arm_group_label>
    <arm_group_label>Standard-therapy Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>The right temporal MECT</intervention_name>
    <arm_group_label>The right temporal and propofol</arm_group_label>
    <arm_group_label>The right temporal and etomidate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bilateral frontal MECT</intervention_name>
    <arm_group_label>Bilateral frontal and propofol</arm_group_label>
    <arm_group_label>Bilateral frontal and etomidate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged over 18 years (when informed consent was got), male or female

          -  Meet International Classification of Diseases-10(ICD-10) diagnostic criteria for
             depression

          -  Scored 18 or above on the HAM-D Scale which included 17 items

          -  Clinical Global Impression(CGI)-severity score â‰¥ 4

          -  Provided written informed consent

        Exclusion Criteria:

          -  Any depressive disorders not due to major depressive disorder

          -  Meet other diagnosis criteria in Diagnostic and Statistical Manual of Mental
             Disorders-IV-Test Revision(DSM-IV-TR) Axis I

          -  With a history of acute or chronic renal failure, liver cirrhosis or active
             hepatopathy

          -  With clinically significant abnormal results of laboratory test, which are considered
             to have impact on treatment efficacy and the safety of participants

          -  With a history of severe or unstable physical disease including nervous system disease
             and myocardial infarction

          -  Undergoing alcoholism or alcohol (or substance) abuse during 30 days or 6 months
             before the trial

          -  With no response to previous ECT treatment

          -  Received transcranial magnetic stimulation treatment in the last 6 months

          -  Allergic to propofol, etomidate and succinylcholine chloride

          -  During pregnancy or lactation

          -  With a history of stroke in the last month

          -  Enrolled in any other clinical trial 30 days prior to the baseline
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Shanghai Mental Health Center</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2014</study_first_submitted>
  <study_first_submitted_qc>February 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 19, 2014</study_first_posted>
  <last_update_submitted>April 19, 2018</last_update_submitted>
  <last_update_submitted_qc>April 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Major Depressive Disorder</keyword>
  <keyword>Modified Electroconvulsive Therapy</keyword>
  <keyword>Cognition</keyword>
  <keyword>Memory</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Etomidate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

